Recursion pharmaceuticals inc RXRX.US Value Analysis

US StockHealth Care
(Powered by Quartr Logo)

RXRX Value Score

3

24

15

Average Growth
  • AI analysis rates RXRX  with a medium value score of 3.
  • It is mainly due to  stable revenue growth, but with concerns regarding unstable operating cash flow.
  • Over the past 3 months, RXRX has maintained an average value rating of 2.5, higher than the rating of 0.9 over the past 3 years, indicating noticeable improvement in enterprise value.
  • Compared to all stocks in the Health Care sector, RXRX has a medium value rating.

RXRX Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/03/04 (Weekly Update)

RXRX Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

RXRX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
-0.53
-32.5%
20.5%
4.51M
-58.6%
-76.3%
-366.8%
2024Q2
-0.34
20.9%
3%
26.08M
158.2%
43.5%
-676.6%
2024Q1
-0.4
-5.3%
14.3%
14.42M
30.9%
8.7%
-662.4%
2023Q4
-0.39
-14.7%
-9.3%
13.79M
13.7%
9%
-853.9%
2023Q3
-0.4
-21.2%
-13%
10.89M
105.5%
-46.5%
-920.8%

Update to 2025/5/8 (Quarterly Update)

RXRX Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

RXRX Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of RXRX from 2021/04 till Now

-
Cumulative Return
-
Annual Return
-
Volatility
-
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from April, 2021 to May, 2025. (Total Trades: 0)

RXRXSectorUS Overall Market
Wining Rate-44%53%
Avg Return-63.1%72.3%
Avg Profit-198.4%166.4%
Avg Loss--44.8%-34.6%
Avg Risk-Reward Ratio-442.5%480.4%

Update to 2025/5/8 (Daily Update)

Top 10 High Relevance to RXRX Value Score